ArticleScientific reports2025
High polyketide synthase gene expression boosts pathogenicity of Klebsiella pneumoniae in the digestive infection.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The pathogenicity of Klebsiella pneumoniae is continuously on the rise owing to variations in virulence. The polyketide synthase (pks) gene plays a crucial role in the expression of microbial virulence genes. However, Klebsiella pneumoniae, often considered a colonizing bacterium, has been shown to possess significant virulence and antibiotic resistance properties, which might be a significant factor contributing to the persistent difficulty in curing clinical gastrointestinal infections. This study analyzed the pks gene expression in Klebsiella pneumoniae and the associated clinical features in digestive infections over the past year. Gene editing technology and genomic analysis were employed to identify the virulence genes of Klebsiella pneumoniae in digestive tract infections. Experimental results demonstrated that a higher proportion of pks-positive Klebsiella pneumoniae were detected in the digestive tracts of clinical patients, and these strains carried more virulence factors. The clbA gene fragment can be utilized independently as a detection fragment for the pks gene. The pks gene may influence the virulence expression of Klebsiella pneumoniae through different signal pathways associated with other virulent genes. Testing for the pks gene can offer experimental evidence to support clinical treatment decisions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.